CTRI/2012/04/002605
Other
未知
Randomized, Double Blind, Placebo Controlled Trial of Periappendiceal Injection of Triamcinolone in Idiopathic Ulcerative Colitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- PGIMER
- Status
- Other
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a.Male or female patients 18 years of age or older with an established diagnosis of IUC
- •b.In clinical remission for at least 3 months on 5\-ASA at a stable dose ranging from 1\.6 to 2\.4 g/day
- •c.Patient had achieved remission with a corticosteroid \> 20 mg/day prednisolone or an alternative medication and had successfully ceased steroid therapy
- •d.Patients undergoing colonoscopy for assessment of the extent of the disease
Exclusion Criteria
- •a.Patients on immunomodulators like azathioprine, 6 mercaptopurine and mycophenolate mofetil
- •b.Patients with severe cardiovascular diseases
- •c.Patients with laboratory abnormalities indicating anemia (hemoglobin \< 9 g/dL), leukopenia, thrombocytopenia, or abnormal coagulation;
- •d.Patients with renal or liver disease, chronic pancreatitis, diabetes mellitus, mental disorders or gallstone
- •e.Patients with infection, sepsis, or pneumonia
- •f.Pregnant or nursing women.
- •g.History of appendectomy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Project goal is eliminate HIV within all systems of the body and to prevent its transmission.HIV/AIDSTuberculosisMalariaupper respiratory tract infectionsPACTR201401000720267Health Gateway (PTY) Ltd200
Completed
Phase 4
Efficacy and Safety of Acne Lotion in the Treatment of Facial Acne VulgarisHealth Condition 1: null- Facial Acne VulgarisCTRI/2011/05/001758Mayer Organics Pvt Ltd50
Active, not recruiting
Phase 1
ATherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]Patients suffering from unilateral lateral epicondylitis, persistent for more than 3 months or recurrent and not having responded to at least one reference treatmentMedDRA version: 20.0 Level: PT Classification code 10014971 Term: Epicondylitis System Organ Class: 10022117 - Injury, poisoning and procedural complicationsEUCTR2017-001709-33-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)150
Active, not recruiting
Not Applicable
Ferric Carboxymaltose Versus Placebo in Patients with Congestive Heart FailureEUCTR2012-001134-33-DEniversitätsklinikum Ulm
Completed
Not Applicable
Effectivenessof L-Arginine supplementation for treatment of patients with pulmonary tuberculosisTuberculosis.Tuberculosis of lung, confirmed by sputum microscopy with or without cultureIRCT201211179855N2Arak University of Medical Sciences60